Global Behcets Disease Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Behcets Disease or Behcet's syndrome, is a rare disorder that causes blood vessel inflammation throughout the body. This is an autoinflammatory condition is where body's natural defence against infection and illness - mistakenly attacks healthy tissue. The major symptoms of Behcets disease are genital and mouth ulcers, red, painful eyes and blurred vision, acne-like spots, headaches, painful, stiff, and swollen joints among others. The rise in incidences of Behcets disease worldwide and growing technological advancements in healthcare industry are key factor driving the market growth.
The increasing prevalence of Behcets disease is driving the global market growth. For instance - as per National Center for Biotechnology Information (NCBI) - as of December 2022, Turkey has the highest prevalence of Behcets disease affecting 420 people per 100,000 population. Additionally, In the United States, the prevalence is estimated at 5.2 people per 100,000 population. Moreover, Behcets UK's estimates - in the United Kingdom the prevalence of Behcets disease is estimated at 0.64 people per 100,000 population. Also, increasing R&D expenditure in healthcare sector and growing prevalence of autoinflammatory conditions would create lucrative growth prospectus for the market over the forecast period. However, the lack of awareness towards Behcets Disease stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Behcets Disease Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific dominated the market in terms of revenue, owing to the high prevalence of Behcets disease and growing healthcare sector in the region. Whereas North America is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising incidents of Behcets diseases and presence of leading market players in the North American region.
Major market players included in this report are:
- Creabilis Limited
- Cell Medica Limited
- Actelion Ltd
- Abbott Laboratories
- Novartis AG
- Les Laboratoires
- Servier SAS
- AbbVie Inc.
- Celgene Corporation
- F. Hoffmann La Roche Ltd.
Recent Developments in the Market:
- In July 2019, the U.S. Food and Drug Administration approved apremilast from Celgene Corporation for the treatment of oral ulcers associated with Behcet's disease.
Global Behcets Disease Market Report Scope:
- Historical Data: 2019-2020-2021
- Base Year for Estimation: 2021
- Forecast period: 2022-2029
- Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: Treatment Type, Symptoms, Region
- Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
- Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Treatment Type
- Corticosteroids
- Immunosuppressive Agents
- Immunomodulators
By Symptoms
- Eyes
- Bowels
- Skin and Mucosa
- Lungs
- Brain
- Bones
- Blood Vessels and Heart
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- RoLA
- Rest of the World
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Behcets Disease Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Behcets Disease Market, by Treatment Type, 2019-2029 (USD Billion)
- 1.2.3. Behcets Disease Market, by Symptoms, 2019-2029 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Behcets Disease Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Behcets Disease Market Dynamics
- 3.1. Behcets Disease Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
- 3.1.1.1. rise in incidences of Behcets disease worldwide
- 3.1.1.2. Growing technological advancements in healthcare industry
- 3.1.2. Market Challenges
- 3.1.2.1. Lack of awareness among individuals
- 3.1.3. Market Opportunities
- 3.1.3.1. Increasing R&D expenditure in healthcare sector
- 3.1.3.2. Growing prevalence of autoinflammatory conditions
Chapter 4. Global Behcets Disease Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.4. Top investment opportunity
- 4.5. Top winning strategies
- 4.6. Industry Experts Prospective
- 4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1. Assessment of the overall impact of COVID-19 on the industry
- 5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Behcets Disease Market, by Treatment Type
- 6.1. Market Snapshot
- 6.2. Global Behcets Disease Market by Treatment Type, Performance - Potential Analysis
- 6.3. Global Behcets Disease Market Estimates & Forecasts by Treatment Type 2019-2029 (USD Billion)
- 6.4. Behcets Disease Market, Sub Segment Analysis
- 6.4.1. Corticosteroids
- 6.4.2. Immunosuppressive Agents
- 6.4.3. Immunomodulators
Chapter 7. Global Behcets Disease Market, by Symptoms
- 7.1. Market Snapshot
- 7.2. Global Behcets Disease Market by Symptoms, Performance - Potential Analysis
- 7.3. Global Behcets Disease Market Estimates & Forecasts by Symptoms 2019-2029 (USD Billion)
- 7.4. Behcets Disease Market, Sub Segment Analysis
- 7.4.1. Eyes
- 7.4.2. Bowels
- 7.4.3. Skin and Mucosa
- 7.4.4. Lungs
- 7.4.5. Brain
- 7.4.6. Bones
- 7.4.7. Blood vessels and Heart
Chapter 8. Global Behcets Disease Market, Regional Analysis
- 8.1. Behcets Disease Market, Regional Market Snapshot
- 8.2. North America Behcets Disease Market
- 8.2.1. U.S. Behcets Disease Market
- 8.2.1.1. Treatment Type breakdown estimates & forecasts, 2019-2029
- 8.2.1.2. Symptoms breakdown estimates & forecasts, 2019-2029
- 8.2.2. Canada Behcets Disease Market
- 8.3. Europe Behcets Disease Market Snapshot
- 8.3.1. U.K. Behcets Disease Market
- 8.3.2. Germany Behcets Disease Market
- 8.3.3. France Behcets Disease Market
- 8.3.4. Spain Behcets Disease Market
- 8.3.5. Italy Behcets Disease Market
- 8.3.6. Rest of Europe Behcets Disease Market
- 8.4. Asia-Pacific Behcets Disease Market Snapshot
- 8.4.1. China Behcets Disease Market
- 8.4.2. India Behcets Disease Market
- 8.4.3. Japan Behcets Disease Market
- 8.4.4. Australia Behcets Disease Market
- 8.4.5. South Korea Behcets Disease Market
- 8.4.6. Rest of Asia Pacific Behcets Disease Market
- 8.5. Latin America Behcets Disease Market Snapshot
- 8.5.1. Brazil Behcets Disease Market
- 8.5.2. Mexico Behcets Disease Market
- 8.5.3. Rest of Latin America Behcets Disease Market
- 8.6. Rest of The World Behcets Disease Market
Chapter 9. Competitive Intelligence
- 9.1. Top Market Strategies
- 9.2. Company Profiles
- 9.2.1. Creabilis Limited
- 9.2.1.1. Key Information
- 9.2.1.2. Overview
- 9.2.1.3. Financial (Subject to Data Availability)
- 9.2.1.4. Product Summary
- 9.2.1.5. Recent Developments
- 9.2.2. Cell Medica Limited
- 9.2.3. Actelion Ltd
- 9.2.4. Abbott Laboratories
- 9.2.5. Novartis AG
- 9.2.6. Les Laboratoires
- 9.2.7. Servier SAS
- 9.2.8. AbbVie Inc.
- 9.2.9. Celgene Corporation
- 9.2.10. F. Hoffmann La Roche Ltd.
Chapter 10. Research Process
- 10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
- 10.2. Research Attributes
- 10.3. Research Assumption